Demand Of Fetal And Neonatal Heart Monitor Is Set To Record A Steady 5.5% Value CAGR By The End Of 2032

Preterm birth is one of the most prevalent cause of stillbirths, or fetal mortality, and neonatal morbidity & mortality. In the U.S. alone, premature births account for nearly 10% of the newborn babies annually.

Insufficient and improper nutrition delivery, a primary cause of preterm birth, has been lined with many health diseases and cardiovascular malignancies.

Increase in the number of stillbirths on the coattails of preterm birth has raised concerns with regard to safety monitoring, such as heart rate monitoring.

Download FREE Sample Copy of This Report:

The development of fetal and neonatal cardiac monitors is still driven by the desire to lower the incidence of preterm deliveries. According to statistics from the National Center for Health Statistics, the US has one of the highest rates of infant mortality among developed countries. The ratio of deaths per live birth continues to worry European governments and medical professionals.

According to the report, makers of fetal and neonatal cardiac monitors will discover that Asia Pacific excluding Japan (APEJ) would be a lucrative market during the assessment period. There has been a concerted effort by governments and healthcare providers to reduce the high infant mortality rates in many nations in the region.

Due to an increase in NICU admissions, the use of foetal and neonatal heart rate monitoring is also rising. During the assessment period, the market for foetal and neonatal heart monitors is likely to expand due to the expanding applications and implementation of monitoring technology in NICUs. Key market players now have more opportunities as a result of the rise of NICUs.

According to the study, rising preterm birth rates in developing nations like India have caused the creation of new neonatal intensive care units (NICUs), which has opened up prospects for the use of foetal and neonatal heart monitors. Although the market for foetal and neonatal heart monitors has a promising future, performance issues and inaccurate data are still a barrier to expansion. Problems with inaccurate heart rate monitoring can produce inaccurate readings, which in turn can produce ambiguity. Manufacturers are concentrating on releasing innovative and original items in the market in an effort to address these issues. Smart pulse foetal monitoring technology was created by Philips Avalon and uses cross channel verification to ensure accurate data. According to the report, manufacturers will continue to prioritise research.

Request Customized Report as Per Your Requirements:

Fetal and Neonatal Heart Monitor Market Taxonomy & Segmentation Analysis

This report also offers a scrutinized study on the market for fetal and neonatal heart monitor in terms of a segmentation analysis.
The market has been divided into five key segments, viz., product type, end-user, modality, and region.

These segments have been analyzed in detail, engulfing market forecasts and estimates at a country and regional level.

The segmentation analysis offered can be useful for the report readers in understanding probable opportunities and potential markets for the target product – fetal and neonatal heart monitor.

A taxonomy table incorporated in the report illustrates all the market segments in a systematic manner as depicted below.
• North America
• Latin America
• Europe
• Japan
Product Type
• Cardiotocograph
• Doppler
• Accessories
• Table Top Devices
• Portable and Hand Held Devices
• Hospitals
• Neonatal Clinics
• Ambulatory Surgical Centers
• Diagnostic Centers

Get Full Access of Complete Report:

Fetal and Neonatal Heart Monitors that Detect Metabolic Disorders an Opportunity for Market Participants

The report finds that market participants have an opportunity of developing fetal and neonatal heart monitors that can diagnose heart rate patterns occurring due to metabolic disorders, such as fetal metabolic acidemia. The fetal and neonatal heart monitors available in the market are not completely successful in detecting metabolic disorders, with many instances going undetected. Manufacturers who are able to launch highly accurate and advanced fetal and neonatal heart monitors in the market can leverage the opportunities emerging in this segment.

Demand for table top fetal and neonatal heart monitor devices is higher than portable and handheld variants. Hospitals and neonatal clinics around the globe prefer table top devices due to workforce familiarity and cost benefits. The report projects demand for table top devices to be higher than portable and handheld devices over the forecast period.

US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Leave a Reply

Your email address will not be published. Required fields are marked *